【摘要】：目的檢測(cè)肺鱗狀細(xì)胞癌(LSCC)中血管生成抑制蛋白1(vasohibin-1)和結(jié)腸癌轉(zhuǎn)移相關(guān)蛋白-1(MACC1)蛋白的表達(dá)及其相互之間的關(guān)系,并探討它們與LSCC患者臨床病理因素的關(guān)系。方法利用免疫組織化學(xué)ElivisionTMplus方法檢測(cè)160例LSCC和80例正常肺組織中vasohibin-1和MACC1蛋白的表達(dá)情況。結(jié)果在LSCC組織中,vasohibin-1和MACC1蛋白的表達(dá)陽性率分別為59.4%和57.5%;對(duì)照組中,vasohibin-1和MACC1蛋白的表達(dá)陽性率分別為11.3%和8.8%,其表達(dá)差異在兩組之間有統(tǒng)計(jì)學(xué)意義(P0.05)。vasohibin-1和MACC1蛋白的表達(dá)陽性率在LSCC患者腫瘤組織的不同分化程度之間、淋巴結(jié)轉(zhuǎn)移與否之間以及TNM不同分期之間差異均有統(tǒng)計(jì)學(xué)意義(P0.05);且vasohibin-1蛋白的表達(dá)陽性率與MACC1蛋白的表達(dá)陽性率之間呈正相關(guān)關(guān)系(P0.001)。Kaplan-Meier生存分析表明在LSCC中vasohibin-1和MACC1蛋白陽性表達(dá)組患者術(shù)后總的生存時(shí)間明顯低于其陰性組患者,log-rank分析其差異均有統(tǒng)計(jì)學(xué)意義。多因素回歸分析表明vasohibin-1和MACC1蛋白的陽性表達(dá)及TNM分期是影響LSCC患者術(shù)后生存的獨(dú)立預(yù)后因子。結(jié)論異常表達(dá)的vasohibin-1和MACC1可能參與了LSCC的發(fā)展,并促進(jìn)其浸潤(rùn)和轉(zhuǎn)移;在LSCC患者中聯(lián)合檢測(cè)vasohibin-1和MACC1蛋白的表達(dá)對(duì)預(yù)測(cè)其發(fā)展和預(yù)后均有重要意義。
[Abstract]:Objective to investigate the expression of angiogenesis inhibitor protein 1 (vasohibin-1) and metastasis associated protein 1 (MACC1) in (LSCC) of lung squamous cell carcinoma and their relationship with clinicopathological factors in patients with LSCC. Methods the expression of vasohibin-1 and MACC1 protein in 160 cases of LSCC and 80 cases of normal lung tissue were detected by immunohistochemical ElivisionTMplus method. Results the positive rates of Vasohibin-1 and MACC1 protein were 59.4% and 57.5% in LSCC and 11.3% and 8.8% in control group, respectively. The difference between the two groups was statistically significant (P0.05) .Vasohibin-1 and MACC1 protein were positive. The rate of sex is between the different differentiation degree of tumor tissue in patients with LSCC. There were significant differences between lymph node metastasis and different stages of TNM (P0.05), and there was a positive correlation between the positive rate of vasohibin-1 protein expression and the positive rate of MACC1 protein expression (P0.001) .Kaplan-Meier survival analysis showed that vasohibin-1 and MACC1 eggs were expressed in LSCC. The total survival time of white positive expression group was significantly lower than that of negative group. Multivariate regression analysis showed that the positive expression of vasohibin-1 and MACC1 protein and TNM stage were independent prognostic factors for postoperative survival of LSCC patients. Conclusion the abnormal expression of vasohibin-1 and MACC1 may participate in the development of LSCC and promote its invasion and metastasis. It is important to detect the expression of vasohibin-1 and MACC1 protein in LSCC patients for predicting their development and prognosis.
【作者單位】： 蚌埠醫(yī)學(xué)院第一附屬醫(yī)院病理科//蚌埠醫(yī)學(xué)院病理學(xué)教研室;
【基金】：安徽省高等學(xué)校自然科學(xué)研究重點(diǎn)項(xiàng)目(KJ2015A269) 安徽省自然科學(xué)基金(1708085MH230) 安徽省高等學(xué)校優(yōu)秀青年人才重點(diǎn)支持計(jì)劃(gxyq ZD2016160)
【分類號(hào)】：R734.2

【參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 周龍書;李李;史文靜;;Vasohibin-1、VEGF在子宮內(nèi)膜腺癌中的表達(dá)及意義[J];中國(guó)婦幼保健;2015年03期

【共引文獻(xiàn)】

相關(guān)期刊論文 前5條

1 武世伍;王一超;慈紅非;陶儀聲;;血管生成抑制蛋白1和結(jié)腸癌轉(zhuǎn)移相關(guān)蛋白-1在肺鱗狀細(xì)胞癌中的表達(dá)及其臨床意義[J];南方醫(yī)科大學(xué)學(xué)報(bào);2017年07期

2 徐瑜;;子宮內(nèi)膜腺癌患者基質(zhì)金屬蛋白酶14和血管內(nèi)皮生長(zhǎng)因子表達(dá)及相關(guān)性研究[J];陜西醫(yī)學(xué)雜志;2017年02期

3 周龍書;黃嬋;史文靜;;子宮內(nèi)膜腺癌組織中Vasohibin-1與MVD的表達(dá)及其相關(guān)關(guān)系的研究[J];中國(guó)醫(yī)學(xué)創(chuàng)新;2016年27期

4 李李;周龍書;史文靜;;Vasohibin-1、VEGF及HIF-1α在子宮內(nèi)膜腺癌中的表達(dá)及意義[J];河北醫(yī)藥;2016年05期

5 唐勇民;;VEGF、IGF-1及其受體在子宮內(nèi)膜癌中的表達(dá)及意義[J];現(xiàn)代實(shí)用醫(yī)學(xué);2015年07期

【二級(jí)參考文獻(xiàn)】

相關(guān)期刊論文 前1條

1 王s，

本文編號(hào)：2237281